Background: Several mobile apps have been designed for patients with a diagnosis of cancer. Unfortunately, despite the promising potential and impressive spread, their effectiveness often remains unclear. Most mobile apps are developed without any medical professional involvement and quality evidence-based assessment. Furthermore, they are often implemented in clinical care before any research is performed to confirm usability, appreciation, and clinical benefits for patients.
Objective: We aimed to develop a new smartphone app (Centro di Senologia della Svizzera Italiana [CSSI]) specifically designed by breast care specialists and patients together to help breast cancer patients better understand and organize their journey through the diagnosis and treatment of cancer. We describe the development of the app and present assessments to evaluate its feasibility, usefulness, and capability to improve patient empowerment.
Methods: A mixed method study with brief longitudinal quantitative data collection and subsequent qualitative semistructured interviews was designed. Twenty breast cancer patients participated in the study (mean age 51 years, SD 10 years). The usability of the app, the user experience, and empowerment were measured after 1 month. The semistructured interviews measured the utility of the app and the necessary improvements.
Results: The app received good responses from the patients in terms of positive perception of the purpose of the app (7/20, 35%), organizing the cure path and being aware of the steps in cancer management (5/20, 25%), facilitating doctor-patient communication (4/20, 20%), and having detailed information about the resources offered by the hospital (2/20, 10%). Correlation and regression analyses showed that user experience increased the level of empowerment of patients (B=0.31, 95% CI 0.22-0.69; P=.009). The interviews suggested the need to constantly keep the app updated and to synchronize it with the hospital's electronic agenda, and carefully selecting the best time to offer the tool to final users was considered crucial.
Conclusions: Despite the very small number of participants in this study, the findings demonstrate the potential of the app and support a fully powered trial to evaluate the empowering effect of the mobile health app. More data will be gathered with an improved version of the app in the second phase involving a larger study sample.
Keywords: breast cancer; breast cancer journey; breast cancer patient; decision-making process; empowerment; mobile app; smartphone app.
©Serena Petrocchi, Chiara Filipponi, Giacomo Montagna, Marta Bonollo, Olivia Pagani, Francesco Meani. Originally published in JMIR Formative Research (https://formative.jmir.org), 10.05.2021.
Conflicts of Interest: None declared.
Hyatt A, Lipson-Smith R, Morkunas B, Krishnasamy M, Jefford M, Baxter K, Gough K, Murphy D, Drosdowsky A, Phipps-Nelson J, White F, White A, Serong L, McDonald G, Milne D. Hyatt A, et al. JMIR Mhealth Uhealth. 2020 Jan 21;8(1):e15593. doi: 10.2196/15593. JMIR Mhealth Uhealth. 2020. PMID: 31961333 Free PMC article.
Ormel I, Onu CC, Magalhaes M, Tang T, Hughes JB, Law S. Ormel I, et al. JMIR Form Res. 2021 Jun 2;5(6):e22970. doi: 10.2196/22970. JMIR Form Res. 2021. PMID: 34076582 Free PMC article.
Barbaric A, Munteanu C, Ross H, Cafazzo JA. Barbaric A, et al. JMIR Form Res. 2022 Dec 6;6(12):e41628. doi: 10.2196/41628. JMIR Form Res. 2022. PMID: 36472895 Free PMC article.
Muro-Culebras A, Escriche-Escuder A, Martin-Martin J, Roldán-Jiménez C, De-Torres I, Ruiz-Muñoz M, Gonzalez-Sanchez M, Mayoral-Cleries F, Biró A, Tang W, Nikolova B, Salvatore A, Cuesta-Vargas AI. Muro-Culebras A, et al. JMIR Mhealth Uhealth. 2021 Dec 1;9(12):e15433. doi: 10.2196/15433. JMIR Mhealth Uhealth. 2021. PMID: 34855618 Free PMC article. Review.
Scott IA, Scuffham P, Gupta D, Harch TM, Borchi J, Richards B. Scott IA, et al. Aust Health Rev. 2020 Feb;44(1):62-82. doi: 10.1071/AH18064. Aust Health Rev. 2020. PMID: 30419185 Review.
Tuominen L, Leino-Kilpi H, Poraharju J, Cabutto D, Carrion C, Lehtiö L, Moretó S, Stolt M, Sulosaari V, Virtanen H. Tuominen L, et al. Support Care Cancer. 2024 May 31;32(6):396. doi: 10.1007/s00520-024-08545-9. Support Care Cancer. 2024. PMID: 38816629 Free PMC article. Review.
Anders C, Moorthy P, Svensson L, Müller J, Heinze O, Knaup P, Wallwiener M, Deutsch TM, Le TV, Weinert L. Anders C, et al. JMIR Hum Factors. 2024 Mar 5;11:e50926. doi: 10.2196/50926. JMIR Hum Factors. 2024. PMID: 38441959 Free PMC article. Clinical Trial.
Alhuwail D, Alhouti A, Alsarhan L. Alhuwail D, et al. JMIR Cancer. 2024 Jan 16;10:e48428. doi: 10.2196/48428. JMIR Cancer. 2024. PMID: 38227353 Free PMC article.
Filipponi C, Chichua M, Masiero M, Mazzoni D, Pravettoni G. Filipponi C, et al. JMIR Cancer. 2023 Jul 3;9:e41594. doi: 10.2196/41594. JMIR Cancer. 2023. PMID: 37399067 Free PMC article.
Franzoi MA, Degousée L, Martin E, Semedo PM, Aupomerol M, Soldato D, Di Meglio A, Chiodi C, Barbier A, Chaouachi H, Renvoisé N, Boinon D, Fasse L, Ribeiro J, Le-Provost JB, Arvis J, Lazorthes C, di Palma M, de Jesus A, Raynard B, Pagès A, Delaloge S, Pistilli B, Scotté F, Vaz-Luis I. Franzoi MA, et al. JCO Oncol Pract. 2023 Jun;19(6):353-361. doi: 10.1200/OP.23.00016. JCO Oncol Pract. 2023. PMID: 37307673 Free PMC article.